INS and metabolic syndrome: Weight gain is not only a frequent cosmetic deterrent to intensification that is known to lead to non-adherence to insulin therapy [34], but can also correlate with various components of the metabolic syndrome [35], predicting increased cardiovascular risk in overweight patients with T1DM [33].